You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萊茵生物(002166.SZ):公司合成生物車間預計將於今年年中投入使用
格隆匯 01-31 09:33

格隆匯1月31日丨萊茵生物(002166.SZ)披露投資者關係活動記錄表顯示,公司合成生物車間預計將於今年年中投入使用。對於合成生物業務的發展規劃,一是圍繞天然甜味劑領域的一些稀有成分,目前技術已經相對成熟,預計今年中期將開始試生產,為公司向客户提供更有性價比、更好口感和風味的復配產品,奠定堅實的基礎。如果一切順利,有望24年就達成三四千萬的銷售規模;二是公司正穩步推進2個新化合物的專利、開展功效性實驗以及相關認證的申請工作,例如美國FDA的GRAS認證、國內的新食品原料和新飼料添加等,持續拓展產品線;三是合成生物學的產能將有利於促進公司與現有大客户之間增加合作空間,公司憑藉領先的分離純化能力已經與部分大客户在發酵液的分離純化方面建立了良好的合作關係,因此我們在未來將有能力為客户提供從合成轉化、分離純化等全鏈條一站式服務。應該説從目前合成生物學的產品管線佈局來看,未來兩年將極具看點。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account